Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Even when weight-related use is approved, many plans require prior authorization, documentation of previous weight-loss attempts, or specific lab results
This is where the strategy needs to change
Basaglar is considered a "follow-on" to Lantus but is not a biosimilar, according to the FDA
GLP-1 medications were originally developed to treat type 2 diabetes, but are also widely prescribed for weight loss
Figure 2 When any component of the insulin signaling pathway fails, it can lead to insulin resistance
Being among the first to offer reduced serving sizes can mitigate any revenue impact of reduced volumes
US$ 29.92
US$ 22.34
US$ 24.77
US$ 20.44
US$ 20.64
US$ 29.29
US$ 21.74
US$ 26.90
00213-0/asset/112731b9-960c-4ae2-b23f-e5e941e446ae/main.assets/gr3_lrg.jpg)
